Laumonnier Yves, Karsten Christian M, Köhl Jörg
Institute for Systemic Inflammation Research, University of Lübeck, 23562 Lübeck, Germany.
Institute for Systemic Inflammation Research, University of Lübeck, 23562 Lübeck, Germany; Division of Immunobiology, Cincinnati Children's Hospital and University of Cincinnati, College of Medicine, Cincinnati, OH 45229, USA.
Mol Immunol. 2017 Sep;89:44-58. doi: 10.1016/j.molimm.2017.05.019. Epub 2017 Jun 7.
The anaphylatoxins (AT) C3a and C5a play important roles as mediators of inflammation. Further, they regulate and control multiple innate and adaptive immune responses through binding and activation of their cognate G protein-coupled receptors, i.e. C3a receptor (C3aR), C5a receptor 1 (C5aR1) and C5a receptor 2 (C5aR2), although the latter lacks important sequence motifs for G protein-coupling. Based on their pleiotropic functions, they contribute not only to tissue homeostasis but drive, perpetuate and resolve immune responses in many inflammatory diseases including infections, malignancies, autoimmune as well as allergic diseases. During the past few years, transcriptome expression data provided detailed insights into AT receptor tissue mRNA expression. In contrast, our understanding of cellular AT receptor expression in human and mouse tissues under steady and inflammatory conditions is still sketchy. Ligand binding studies, flow cytometric and immunohistochemical analyses convincingly demonstrated tissue-specific C5aR1 expression in various cells of myeloid origin. However, a detailed map for C3aR or C5aR2 expression in human or mouse tissue cells is still lacking. Also, reports about AT expression in lymphoid cells is still controversial. To understand the multiple roles of the ATs in the innate and adaptive immune networks, a detailed understanding of their receptor expression in health and disease is required. Recent findings obtained with novel GFP or tdTomato AT-receptor knock-in mice provide detailed insights into their expression pattern in tissue immune and stroma cells. Here, we will provide an update about our current knowledge of AT receptor expression pattern in humans and mice.
过敏毒素(AT)C3a和C5a作为炎症介质发挥着重要作用。此外,它们通过与其同源G蛋白偶联受体(即C3a受体(C3aR)、C5a受体1(C5aR1)和C5a受体2(C5aR2))结合并激活来调节和控制多种先天性和适应性免疫反应,尽管后者缺乏G蛋白偶联的重要序列基序。基于它们的多效性功能,它们不仅有助于组织稳态,而且在包括感染、恶性肿瘤、自身免疫以及过敏性疾病在内的许多炎症性疾病中驱动、维持和解决免疫反应。在过去几年中,转录组表达数据提供了关于AT受体组织mRNA表达的详细见解。相比之下,我们对人和小鼠组织在稳态和炎症条件下细胞AT受体表达的了解仍然很粗略。配体结合研究、流式细胞术和免疫组织化学分析令人信服地证明了C5aR1在各种髓系来源细胞中的组织特异性表达。然而,人类或小鼠组织细胞中C3aR或C5aR2表达的详细图谱仍然缺乏。此外,关于AT在淋巴细胞中表达的报道仍然存在争议。为了了解AT在先天性和适应性免疫网络中的多种作用,需要详细了解它们在健康和疾病中的受体表达。最近用新型绿色荧光蛋白(GFP)或红色荧光蛋白(tdTomato)AT受体敲入小鼠获得的研究结果提供了关于它们在组织免疫和基质细胞中表达模式的详细见解。在这里,我们将提供关于人类和小鼠AT受体表达模式的当前知识的最新情况。